InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: None

Tuesday, 04/17/2018 3:14:51 AM

Tuesday, April 17, 2018 3:14:51 AM

Post# of 38634
Couldn't find any reason for the drastic drop in Revenue; but this explains why they had to make the new offerings.

IPCI is surely a good fit for an OTC company; it looks like the spent some moeny on trials but they didn't communicate when they started (as ALL other biotechs do) and on which product.

They still have 2 products shelved, for which they are considering international commercialization (China ?) ...TIME is MONEY for everybody except them !!

China...how low does it take to sign up an Agreement ? Or are they first incurring costs, setting up, etc and then go for the Agreement ?

Consistently disappointing over the last 2 years...I would say over the entire period following the Focalin FDA mess.